Debabani Roy Chowdhury

Co-founder and Director at Mestastop Solutions

Role: Director at Mestastop® Solutions
Location: Bengaluru, KA, IN
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

Experience

Director
Mestastop® Solutions
Nov 2019 — Present · Bengaluru, IN
The company is focused on understanding metastasis biology and creating an unique platform for metastasis drug discovery and diagnostics. Role is to supervise all molecular biology efforts to create genetically engineered cell lines having different plasticity ratio and lead a team of scientists in characterizing tumor cells as per their plasticity ratio and understand their functional responses in the metastatic cascade according to those ratios.Responsible for laboratory management.

Skills

Tissue Culture
Genetics
Immunoprecipitation
In Vitro
Molecular Genetics
Polymerase Chain Reaction (Pcr)
Transfection
Cell
Sds-Page
Molecular Cloning
Cell Biology
Qpcr
Immunofluorescence
Protein Purification
Epigenomics
Biochemistry
Molecular Biology
Fluorescence Microscopy
Confocal Microscopy
Immunology
Flow Cytometry
Pcr
Cell Culture
Bioinformatics
Protein Expression
Western Blotting
Rt-Pcr

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@mestastop.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Mestastop® Solutions

Biotechnology Research · 22 employees · Founded 2018 · Marlton, New Jersey, United States

Cancer can be broken down into four parts; mainly initiation, progression, immunosuppression, and finally metastasis, leading to death. Initiation and progression happen due to genetic reasons along with the interplay of the tumor microenvironment, whereas immunosuppression is the inefficiency of the body’s immune system to recognize and destroy cancer cells. Metastasis is the movement of tumor cells through the blood and the formation of multiple tumors into different secondary sites of the body. Metastasis is responsible for almost 90% of cancer deaths. Unfortunately, though cancer treatment has advanced with targeted therapy and immunotherapy, there is still a huge gap as none of them addresses metastasis. One of the main reasons for these are the challenges faced in advancing a molecule targeting metastasis; from suitable In vitro models to the perfect animal model that will closely resemble the biology without alleviating cost and timelines. Mestastop aims to provide a solution for such challenges with their unique proprietary platforms, METAssay, METSCAN, and METVivo.

mestastop.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.